XML 33 R21.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

EQUITY TRANSACTIONS (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2024
Equity [Abstract] |
Schedule of warrant activity |
Schedule of warrant activity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Fiscal Year Ended March 31, |
|  | 2024 |  |  | 2023 |
|  | Warrants |  |  | Weighted Average Exercise Price |  |  | Warrants |  |  | Weighted Average Exercise Price |
Outstanding, beginning of year |  |  | 32,676 |  |  | $ | 20.09 |  |  |  | 57,678 |  |  | $ | 112.11 |
Granted |  |  | – |  |  | $ | N/A |  |  |  | – |  |  | $ | N/A |
Exercised |  |  | – |  |  | $ | N/A |  |  |  | – |  |  | $ | N/A |
Cancelled/Forfeited |  |  | – |  |  | $ | N/A |  |  |  | (25,002 | ) |  | $ | 232.38 |
Outstanding, end of year |  |  | 32,676 |  |  | $ | 20.09 |  |  |  | 32,676 |  |  | $ | 20.09 |
Exercisable, end of year |  |  | 32,676 |  |  | $ | 20.09 |  |  |  | 32,676 |  |  | $ | 20.09 |
Weighted average estimated fair value of warrants granted |  |  |  |  |  | $ | N/A |  |  |  |  |  |  | $ | N/A |
Schedule of warrant activity exercisable and outstanding |
Schedule of warrant activity exercisable and outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  | Warrants Outstanding |  |  |  | Warrants Exercisable |
Range of Exercise Prices |  |  | Number Outstanding |  |  |  | Weighted Average Remaining Life (Years) |  |  |  | Weighted Average Exercise Price |  |  |  | Number Outstanding |  |  |  | Weighted Average Exercise Price |
$18.75 or Below |  |  | 20,217 |  |  |  | .71 |  |  | $ | 15.66 |  |  |  | 20,217 |  |  | $ | 15.66 |
$25.00 - $27.50 |  |  | 12,459 |  |  |  | .81 |  |  | $ | 27.28 |  |  |  | 12,459 |  |  | $ | 27.28 |
|  |  | 32,676 |  |  |  |  |  |  |  |  |  |  |  | 32,676 |  |  |  |  |
The detail of the warrants outstanding and exercisable as of March 31, 2023 is as follows:
|  |  | Warrants Outstanding |  |  |  | Warrants Exercisable |
Range of Exercise Prices |  |  | Number Outstanding |  |  |  | Weighted Average Remaining Life (Years) |  |  |  | Weighted Average Exercise Price |  |  |  | Number Outstanding |  |  |  | Weighted Average Exercise Price |
$18.75 or Below |  |  | 20,217 |  |  |  | 1.71 |  |  | $ | 15.66 |  |  |  | 20,217 |  |  | $ | 15.66 |
$25.00 - $27.50 |  |  | 12,459 |  |  |  | 1.81 |  |  | $ | 27.28 |  |  |  | 12,459 |  |  | $ | 27.28 |
|  |  | 32,676 |  |  |  |  |  |  |  |  |  |  |  | 32,676 |  |  |  |  |
Schedule of options outstanding that have vested and are expected to vest |
Schedule of options outstanding that have vested and are expected to vest |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term in Years |
Vested |  |  | 57,813 |  |  | $ | 19.41 |  |  |  | 6.96 |
Expected to vest |  |  | 28,653 |  |  | $ | 15.01 |  |  |  | 7.78 |
Total |  |  | 86,466 |  |  |  |  |  |  |  |  |
Schedule of stock option activity |
Schedule of stock option activity |  |  |  |  |  |  |  |  |  |  |  |
|  | Fiscal Year Ended March 31, |
|  | 2024 |  |  | 2023 |
|  | Options |  |  | Weighted Average Exercise Price |  |  | Options |  |  | Weighted Average Exercise Price |
Outstanding, beginning of year |  |  | 171,825 |  |  | $ | 22.4 |  |  |  | 166,595 |  |  | $ | 23.1 |
Granted |  |  | – |  |  | $ | – |  |  |  | 12,222 |  |  | $ | 9.50 |
Cancelled/Forfeited |  |  | (85,359 | ) |  | $ | 26.89 |  |  |  | (6,992 | ) |  | $ | 17.70 |
Outstanding, end of year |  |  | 86,466 |  |  | $ | 17.95 |  |  |  | 171,825 |  |  | $ | 22.4 |
Exercisable, end of year |  |  | 57,813 |  |  | $ | 19.41 |  |  |  | 75,554 |  |  | $ | 24.5 |
Weighted average estimated fair value of options granted |  |  |  |  |  | $ | N/A |  |  |  |  |  |  | $ | N/A |
Schedule of nonvested shares |
Schedule of nonvested shares |  |  |  |  |  |  |  |
|  | Shares |  |  | Weighted Average Grant Date Fair Value |
Nonvested stock options at April 1, 2023 |  |  | 96,273 |  |  | $ | 19.99 |
Vested |  |  | (21,934 | ) |  | $ | 1.59 |
Forfeited |  |  | (45,686 | ) |  | $ | 2.55 |
Nonvested stock options at March 31, 2024 |  |  | 28,653 |  |  |  |  |
Schedule of detail of options outstanding and exercisable by exercise price |
| Schedule of detail of options outstanding and exercisable by exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Options Outstanding |  |  |  | Options Exercisable |
| Exercise Prices |  |  |  | Number Outstanding |  |  |  | Weighted Average Remaining Life (Years) |  |  |  | Weighted Average Exercise Price |  |  |  | Number Outstanding |  |  |  | Weighted Average Exercise Price |
| $6.90 - $16.80 |  |  |  | 62,204 |  |  |  | 7.48 years |  |  | $ | 13.24 |  |  |  | 38,589 |  |  | $ | 13.48 |
| $25.20 |  |  |  | 24,178 |  |  |  | 6.76 years |  |  | $ | 25.20 |  |  |  | 19,140 |  |  | $ | 25.20 |
| $1,425.00 |  |  |  | 84 |  |  |  | .18 years |  |  | $ | 1,425.00 |  |  |  | 84 |  |  | $ | 1,425.00 |
|  |  |  |  | 86,466 |  |  |  |  |  |  |  |  |  |  |  | 57,813 |  |  |  |  |
Schedule of RSUs |
Schedule of RSUs |  |  |
|  | Shares |
Nonvested RSUs at April 1, 2023 |  |  | – |
Granted |  |  | 54,428 |
Vested |  |  | (34,378 | )
Tax withholding payments or tax equivalent payments for net share settlement of restricted stock units |  |  | (15,165 | )
Nonvested RSUs at March 31, 2024 |  |  | 4,885 |
Schedule of stock-based compensation |
Schedule of stock-based compensation |  |  |  |  |  |
|  | Fiscal Year Ended |
|  | March 31, 2024 |  |  | March 31, 2023 |
Vesting of restricted stock units |  | $ | 206,250 |  |  | $ | 175,000 |
Vesting of stock options |  |  | 1,013,120 |  |  |  | 876,898 |
Total Stock-Based Compensation |  | $ | 1,219,370 |  |  | $ | 1,051,898 |

X
- References No definition available. + Details
Name: | aemd_SummaryOfWarrantActivityExercisableAndOutstandingTableTextBlock
Namespace Prefix: | aemd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (e)(1) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration